Navigation Links
Cleveland Clinic develops clinical screening program for no.1 genetic cause of colon cancer
Date:2/14/2013

dergo proactive colon and other cancer screening for the earliest diagnoses, lives are saved.

The study recommends that a successful program should eliminate "silos" and instead include collaborative representation from colorectal surgery, gastroenterology, gynecology, pathology, genetics, as well as bioethics and oncology. The program must also designate who is to report results to patients and facilitate genetic counseling/testing referral. With clearly assigned roles for patient communication and education, outcomes resulting from Lynch syndrome will be significantly improved.

Led by Charis Eng, M.D., Ph.D., Hardis Chair and Founding Director of the Cleveland Clinic Lerner Research Institute's Genomic Medicine Institute, the researchers studied three approaches, moving certain responsibilities (determining which colorectal cancer patients should receive genetic counseling/testing for Lynch syndrome and contacting the patients with results and recommendations) from the surgeon to genetic counselors. Genetic counselors who received genetic pathology reports on colorectal tumor sections, determined patients who fit criteria consistent with Lynch syndrome, and reached out to patients for further testing saw an increase in referrals and number of patients tested for and diagnosed with Lynch syndrome, the study found.

The Cleveland Clinic researchers have addressed one of the two genomic medicine agenda items of the CDC's Healthy People 2020.

"One of the goals of Healthy People 2020 is to identify as many people who have inherited colon cancer as possible, so they may be referred to genetics professionals for genetic counseling, and management recommendations," said Dr. Eng. "This paper shows successful implementation of a rapid, cost-effective system-wide screening to detect potential Lynch syndrome. Individuals with Lynch syndrome can get colon cancer at a very young age, are susceptible to multiple cases of the disease, and a
'/>"/>

Contact: Laura Ambro
ambrol@ccf.org
216-636-5876
Cleveland Clinic
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
2. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
3. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
4. New clinical trial explores novel noninvasive colon cancer screening test
5. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
6. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
7. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
8. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
9. AAO-HNS releases updated Clinical Indicators
10. Sequencing works in clinical setting to help -- finally -- get a diagnosis
11. VolitionRX Raises Over $1 Million To Begin Clinical Trials of Blood Based Diagnostic Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 According to a ... (Hardware, Software, Services), by Applications (Surveillance (Airborne, Maritime, ... End-Users (Military & Defense & Commercial) - Global ... Market is expected to grow from $7252.0 Million ... a Compound Annual Growth Rate (CAGR) of 6.6%. ...
(Date:5/21/2015)... 2015 The Sync Project™ , a ... health, today announced a collaborative partnership with Berklee,s ... center on collaboration on original research, joint course development ... the collaboration, The Sync Project and BerkleeICE are exploring ... in the 2015-2016 academic year.  The ...
(Date:5/20/2015)... , May 20, 2015 ... ) has announced the addition of ... Global Iris Recognition Market"  report to ... ,This research service analyses trends in ... government and commercial sectors, globally. Despite ...
Breaking Biology News(10 mins):Thermal Imaging Market Worth $9,998.9 Million by 2020 2Thermal Imaging Market Worth $9,998.9 Million by 2020 3Thermal Imaging Market Worth $9,998.9 Million by 2020 4The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... release is available in Spanish . , AgroAtlas ... of 100 crops; 640 species of crop diseases, pests, and ... neighboring countries. Downloadable maps and geographic information system (GIS) software ... relating major wheat production areas to concentrations of Russian wheat ...
... neurosurgery to bar code readers, lasers have been used in ... the late 1950,s. Now, with the work being done in ... way to use lasers to study the splicing of pre-messenger ... advanced organisms, including human life. This process of splicing is ...
... research led by UC Davis and Stanford University found that ... biologists had thought. The study, published today in the ... estimate of white shark numbers in the northeast Pacific Ocean. ... known white-shark populations (the others are in Australia/New Zealand and ...
Cached Biology News:USDA and Russian scientists develop high-tech crop map 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 2Brandeis researchers use lasers, custom microscope to show gene splicing process in real time 3First census finds surprisingly few white sharks off California 2
(Date:5/20/2015)... 20, 2015  Marc Tessier-Lavigne, president of The ... $100 million from The Marie-Josée and Henry R. ... building that will be the centerpiece of the ... Henry R. Kravis Research Building, two stories high, ... approximately three city blocks following the shoreline of ...
(Date:5/20/2015)... May 20, 2015  Cypher Genomics, Inc., a ... with Celgene Corporation to apply Cypher,s Coral TM ... associate with patient response to innovative medicines. The ... help accelerate patient access to the right medicine ... research and development and potentially inform new companion ...
(Date:5/20/2015)... 19, 2015 Research and Markets ... the "Bone Morphogenetic Proteins Market (Types : ... and Oral - Maxillofacial) - Global Industry Analysis, ... 2022" report to their offering. ... based on the types of recombinant BMPs, applications, ...
(Date:5/20/2015)... France, Cambridge, MA (PRWEB) May 20, 2015 ... high quality transporter assay services for Drug-Drug Interactions ... and Rhenovia Pharma, a world leader in assessing ... Translational Quantitative Systems Pharmacology supported by biosimulation, announced ... , The agreement allows both companies to expand ...
Breaking Biology Technology:The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 2The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 3The Marie-Josee and Henry R. Kravis Foundation Provides Landmark Gift of $100 Million to The Rockefeller University 4Cypher Genomics Collaborates with Celgene Corporation to Identify Novel Genomic Biomarkers 2Global Bone Morphogenetic Proteins Market Industry Analysis 2014 - 2022 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... WORCESTER, Mass., Jan. 25, 2011 Generex Biotechnology Corporation ... GNBT ) today announced that it entered into ... January 24, 2011.  The investors have agreed to purchase ... common stock and warrants to purchase shares of common ...
... NEW YORK, Jan. 25, 2011 Reportlinker.com ... is available in its catalogue: ... Strategic Implications of Emerging Reimbursement, Technological and ... http://www.reportlinker.com/p0365288/Future-US-In-Vitro-Diagnostics-Market-Strategic-Implications-of-Emerging-Reimbursement-Technological-and-Market-Trends-through-2018.html How ...
... 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: ... China-based biotechnology company focused on researching, developing, manufacturing ... has received official notification from China,s State Food ... for a TPIAO label extension for the treatment ...
Cached Biology Technology:Generex Announces $3.0 Million Capital Investment 2Generex Announces $3.0 Million Capital Investment 3Generex Announces $3.0 Million Capital Investment 4Reportlinker Adds Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends Through 2018 23SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP 23SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP 33SBio Inc. Receives SFDA Approval for TPIAO Label Extension for the Treatment of ITP 4
IkappaB-alpha (112B2) Mouse mAb...
...
Dopamine D2 and D3 receptor, human and possibly mouse. AB1502 detects 40 ng of dopamine receptor peptide by ELISA. AB1502 is not neutralizing....
Rabbit polyclonal to SpUlp2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: SNNERQSLSSGSND, corresponding to amino acids 622-635 of Schizosaccharomyces pombe SpUlp2...
Biology Products: